D.A. Davidson & CO. Has $2.92 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

D.A. Davidson & CO. boosted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 25.6% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 177,481 shares of the real estate investment trust’s stock after acquiring an additional 36,212 shares during the quarter. D.A. Davidson & CO.’s holdings in Healthpeak Properties were worth $2,916,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Fiduciary Trust Co boosted its holdings in Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares in the last quarter. Patton Fund Management Inc. increased its holdings in shares of Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock valued at $209,000 after acquiring an additional 648 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Healthpeak Properties by 1.9% during the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after acquiring an additional 718 shares in the last quarter. Quantum Portfolio Management LLC raised its position in shares of Healthpeak Properties by 2.5% during the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock worth $483,000 after purchasing an additional 728 shares during the period. Finally, Intrua Financial LLC raised its position in shares of Healthpeak Properties by 1.1% during the first quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock worth $1,096,000 after purchasing an additional 744 shares during the period. 93.57% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOC has been the topic of a number of recent research reports. Scotiabank increased their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Citigroup boosted their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. JPMorgan Chase & Co. upped their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. BMO Capital Markets raised their price objective on shares of Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. Finally, Wells Fargo & Company lifted their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties has an average rating of “Hold” and an average target price of $20.62.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $22.52 on Monday. The company has a market cap of $15.53 billion, a PE ratio of 70.39, a price-to-earnings-growth ratio of 3.50 and a beta of 1.02. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.62. The business has a 50 day moving average price of $20.47 and a 200-day moving average price of $18.25. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.4%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.